Dr. Kave Moloudi is a highly accomplished researcher whose scientific contributions in biomedical sciences, molecular biology, and nanotechnology have established him as a rising figure in advanced cancer therapeutics, with a publication record that includes 26 documents, an h-index of 15, and 559 citations by 487 documents. He has cultivated a strong academic foundation through progressive training in biomedical sciences, radiobiology, radiation protection, and medical imaging, supported by extensive laboratory and research experience across multidisciplinary scientific environments. Dr. Kave Moloudi’s academic journey reflects deep engagement with biological systems, cancer mechanisms, and therapeutic innovations, enabling him to bridge fundamental science with translational medical applications. His professional experience spans teaching, research, and laboratory leadership, where he has contributed to scientific advancements in nanomedicine, photodynamic therapy, multimodal imaging, and biomaterials. Throughout his career, he has worked on developing and characterizing nanocarriers, exploring cell death pathways, studying tumor microenvironments, and designing combined therapeutic platforms that integrate photodynamic, radiotherapeutic, and chemotherapeutic strategies. He has also published widely on fluorescent imaging agents, liposomal nanocarriers, radiosensitizers, stem cell responses to ionizing radiation, and the biological effects of natural compounds in oncological contexts. His work often centers on enhancing therapeutic precision, overcoming tumor hypoxia, and improving diagnostic capabilities through innovative imaging modalities. Dr. Kave Moloudi’s research interests span nanotheranostics, 3D cell culture models, cancer imaging, molecular radiobiology, and advanced drug delivery systems, demonstrating a consistent commitment to pushing the boundaries of current therapeutic and diagnostic technologies. His scholarly impact extends globally through numerous peer-reviewed publications, review articles, and collaborative projects that highlight his expertise in integrating nanotechnology with medical science. In conclusion, Dr. Kave Moloudi stands out as a dedicated and forward-thinking scientist whose contributions continue to shape the evolving landscape of cancer research, molecular imaging, and nanomedicine, with his citation metrics and broad research portfolio reflecting both the depth and influence of his academic and scientific achievements.

Profile: Scopus | Orcid | Google Scholar | Linkedin 

Featured Publications:

• Moloudi, K., Abrahamse, H., & George, B. P. (2024). Nanotechnology-mediated photodynamic therapy: Focus on overcoming tumor hypoxia. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 16(1), e1937.

• Moloudi, K., Abrahamse, H., & George, B. P. (2025). Overcoming photodynamic therapy resistance via DNA repair inhibitors: Advanced review. Photodiagnosis and Photodynamic Therapy, 54, 104724.

• Moloudi, K., & Haghdoost, S. (2025). An Update on Role of Ionizing Radiation to Enhance Proliferation and Differentiation of Normal Stem Cells via Activation of NRF2 Pathway: Review. Antioxidants, 14(8), 986.

• Moloudi, K., Abrahamse, H., & George, B. P. (2023). Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: Review. Oncology (Frontiers in Oncology). 12 July 2023. Frontiers

• Moloudi, K., Abrahamse, H., & George, B. P. (2024). Co-loading Radio-photosensitizer Agents on Polymer and Lipid-based Nanocarriers for Radio-photodynamic Therapy Purposes: Review. Current Pharmaceutical Design.

• Moloudi, K., Abrahamse, H., & George, B. P. (2023). Understanding the photodynamic therapy induced bystander and abscopal effects: A review. Antioxidants, 12(7), 1434.

• Moloudi, K., Abrahamse, H., George, B. P.(2023). Up-regulation of ABCG2 by MYBL2 deletion drives chlorin e6-mediated photodynamic therapy resistance in colorectal cancer. Photodiagnosis and Photodynamic Therapy, 42,